BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 15330927)

  • 1. Eradication therapy in Helicobacter pylori positive peptic ulcer disease: systematic review and economic analysis.
    Ford AC; Delaney BC; Forman D; Moayyedi P
    Am J Gastroenterol; 2004 Sep; 99(9):1833-55. PubMed ID: 15330927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eradication therapy for peptic ulcer disease in Helicobacter pylori-positive people.
    Ford AC; Gurusamy KS; Delaney B; Forman D; Moayyedi P
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD003840. PubMed ID: 27092708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients.
    Ford A; Delaney B; Forman D; Moayyedi P
    Cochrane Database Syst Rev; 2003; (4):CD003840. PubMed ID: 14583996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients.
    Ford AC; Delaney BC; Forman D; Moayyedi P
    Cochrane Database Syst Rev; 2006 Apr; (2):CD003840. PubMed ID: 16625592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients.
    Ford A; Delaney B; Forman D; Moayyedi P
    Cochrane Database Syst Rev; 2004 Oct; (4):CD003840. PubMed ID: 15495066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cost-effectiveness of population Helicobacter pylori screening and treatment: a Markov model using economic data from a randomized controlled trial.
    Mason J; Axon AT; Forman D; Duffett S; Drummond M; Crocombe W; Feltbower R; Mason S; Brown J; Moayyedi P;
    Aliment Pharmacol Ther; 2002 Mar; 16(3):559-68. PubMed ID: 11876711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immediate eradication of Helicobacter pylori in patients with previously documented peptic ulcer disease: clinical and economic effects.
    Fendrick AM; McCort JT; Chernew ME; Hirth RA; Patel C; Bloom BS
    Am J Gastroenterol; 1997 Nov; 92(11):2017-24. PubMed ID: 9362183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
    Asaka M; Kato M; Sugiyama T; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S;
    J Gastroenterol; 2003; 38(4):339-47. PubMed ID: 12743773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Helicobacter pylori eradication therapy in cirrhotic patients with peptic ulcer disease.
    Mitrică D; Pleşa A; Constantinescu R; Drug V; Stanciu C
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):367-74. PubMed ID: 21870725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of a Helicobacter pylori treatment strategy on health care expenditures in patients with peptic ulcer disease and dyspepsia.
    Kearney DJ; Liu CF; Crump C; Brousal A
    Am J Gastroenterol; 2003 Sep; 98(9):1952-62. PubMed ID: 14499771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eradication of Helicobacter pylori improves the healing rate and reduces the relapse rate of nonbleeding ulcers in patients with bleeding peptic ulcer.
    Arkkila PE; Seppälä K; Kosunen TU; Haapiainen R; Kivilaakso E; Sipponen P; Mäkinen J; Nuutinen H; Rautelin H; Färkkilä MA
    Am J Gastroenterol; 2003 Oct; 98(10):2149-56. PubMed ID: 14572560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review article: clinical aspects of Helicobacter pylori eradication therapy in peptic ulcer disease.
    Penston JG
    Aliment Pharmacol Ther; 1996 Aug; 10(4):469-86. PubMed ID: 8853751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Helicobacter pylori eradication on the healing and recurrence of peptic ulcer: combination therapy with low-dose omeprazole and clarithromycin.
    Uemura N; Okamoto S; Mukai T; Yamaguchi S; Kaji M; Hrruma K; Sumii K; Kajiyama G
    Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S67-9. PubMed ID: 8574740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Helicobacter pylori eradication in ulcer patients. Quality of life improves, costs decline].
    MMW Fortschr Med; 2003 Aug; 145(33-34):55. PubMed ID: 14526577
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of Helicobacter pylori eradication and antisecretory maintenance therapy on peptic ulcer recurrence in cirrhotic patients: a prospective, cohort 2-year follow-up study.
    Tzathas C; Triantafyllou K; Mallas E; Triantafyllou G; Ladas SD
    J Clin Gastroenterol; 2008 Jul; 42(6):744-9. PubMed ID: 18277886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. H pylori in patients with peptic ulcer disease.
    Strickland C
    J Fam Pract; 1998 Feb; 46(2):117. PubMed ID: 9487314
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of Helicobacter pylori eradication on peptic ulcer disease complicated with outlet obstruction.
    Taskin V; Gurer I; Ozyilkan E; Sare M; Hilmioglu F
    Helicobacter; 2000 Mar; 5(1):38-40. PubMed ID: 10672050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter pylori and peptic ulcer.
    Korman MG; Tytgat GN
    Scand J Gastroenterol Suppl; 1995; 210():92-6. PubMed ID: 8578219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of Helicobacter pylori eradication therapy in duodenal ulcer disease.
    Jönsson B
    Scand J Gastroenterol Suppl; 1996; 215():90-5. PubMed ID: 8722390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
    Ohara T; Kanoh Y; Higuchi K; Arakawa T; Morisita T
    Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.